WASHINGTON, Jan. 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) has expanded the approved use of a drug to treat certain types of breast cancer that have spread and whose tumors have a specific inherited genetic mutation. It is the first time any drug has been approved to ...
“The future of breast cancer surgery is one where we can achieve minimal change to a woman’s body image and quality of life, and give our patients the confidence and courage to face the rest of her treatments.” Oncoplastic surgery: A new option ...
BEIJING, March 30 (Xinhua) -- China is moving to promote a package of breast cancer prevention and treatment standards across the country, hoping to further prolong patients' survival time and narrow the diagnosis and treatment gap between urban and rural areas. A series of guidelines covering b...
regimen for the treatment of cancer with HER-2 / neu overexpression / amplification, after the completion of adjuvant therapy and surgery, and cancer of HER-2 / neu overexpression / amplification, the course of neratinib therapy I describe a regimen comprising the step of delivering to the ...
By the presented information, you will now be able to point out the uncommon signs of breast cancer. Many of these signs are left unnoticed or overlooked and neglected, assuming them to be normal. However, realizing that those can be the signs of breast cancer can help you visit the expert...
At diagnosis, breast cancer cells may be found in the breast tissue only, in the axillary lymph nodes under the arm, or in more distant sites in the body. Based on where the cancer is found, breast cancer is assigned a stage, from I to IV. Stage IV breast cancer, also called metasta...
V, or VI for treating triple negative breast Compounds useful for treating breast cancer include those compounds of formulae I, II, III, IV, V, or VI that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer....
Recently, the American Heart Association published a striking statement for women who have undergone chemotherapy and/or radiation treatment for breast cancer: namely, that these therapies can contribute to heart failure or other heart problems, even many years after the conclusion of cancer treatment....
How to publish in this journal Scope Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place"...
We compared the initial treatment of 383 patients with breast cancer in two central London teaching hospitals during 1986 with the guidelines of the King's Fund Consensus Conference for breast cancer treatment held in London the same year. The majority of patients (68%) received lumpectomy and ...